Zimmer axes jobs to cut costs ahead of med-tech tax | Personnel Moves
March 6, 2012 by Arezu Sarvestani
Zimmer plans cuts and outsourcing at its Warsaw, Ind., headquarters partially to offset the impending burden of a 2.3% medical device tax.
Industry lobby AdvaMed estimates that the tax will result in 43,000 jobs lost in the medical device field.
Here are latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice's compilation of the latest personnel moves.
Pathfinder names former Medtronic GM Jim Cloar president & CEO
Pathfinder Therapeutics, maker of "surgical GPS" products for the abdomen, named Jim Cloar president & CEO. Cloar was formerly general manager of the imaging division for Medtronic (NYSE:MDT). Read more
- Angeion names Wendy Lynch, co-director of Alatrum Institute's Center for Consumer Choice, to board of directors
- pSivida adds HeartWare International CEO Douglas Godshall to board
- Neurotech announces new territory manager for Minnesota and Western Wisconsin
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
- Medical device sales: Wright Medical's pilot program on rep-less sales process worth watching
- Raising an early warning in the ICU: T3
- Staff shakeup underway at Russian medical device regulator
- Heart Rhythm Society 2013 Scientific Session wrap-up
- Physician blogger insights on social media
Navigation
NEWS
Pluristem launches Phase I clinical trial to treat tendonitis with stem cells
Pluristem is seeking clinical proof that stem cell therapy can benefit patients with chronic...
GE Healthcare unveils soft tissue imaging technology
GE Healthcare introduces Mavric SL, a novel magnetic resonance imaging technique for joint...
Hip implants: Johnson & Johnson's DePuy will stop selling metal-on-metal implants
Johnson & Johnson subsidiary DePuy Orthopaedics plans to phase out sales of all of its metal-on-...
Combat Medical Systems wins 1st-of-its kind approval for tourniquet
The FDA approves a novel combat-ready clamp to treat wounds most commonly associated with roadside or...
Vascular Solutions CEO: Boston Scientific's alleged patent infringement 'blatant'
Vascular Solutions CEO Howard Root says alleged infringement by Boston Scientific's Guidezilla "is...
